VDR SNPs & 25OHD Correlated With Dyslipidemia

January 12, 2021 updated by: Zhou Ji-Chang, Shenzhen Center for Chronic Disease Control
The project was aimed to explore the associations of single nucleotide polymorphisms (SNPs) of vitamin D receptor gene with specific circulating lipids in adult Chinese. The circulating 25-hydroxyvitamin D concentration was also tested to explore its interactions with SNPs in the associations.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1987

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Shenzhen, Guangdong, China, 518020
        • Shenzhen Center for Chronic Disease Control

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 81 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult volunteers visiting a health examination center in Shenzhen city of Guangdong province, China were recruited.

A total of 1,987 adults were included in the analysis, aged from 20 to 81 years old. Among them, there were 1,124 females aged 39 (31 - 49) years old and 863 males aged 36 (30 - 44) years old.

Description

Inclusion Criteria:

  • 1) ≥ 20 years old Han Chinese;
  • 2) living in Shenzhen for > 2 years;
  • 3) free of liver diseases, renal diseases, and any cancers in the past 6 months; and
  • 4) not in pregnancy for women.

Exclusion Criteria:

  • 1) had severe organic diseases,
  • 2) had acute infection symptoms, allergic diseases, and malignant tumors,
  • 3) had a family history of genetic diseases,
  • 4) took VD supplements in the past 6 months,
  • 5) took medicines to control lipid levels within 12 hours, or
  • 6) took diuretics, did strenuous exercise, or overate within 24 hours before the test.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SNPs of VDR
Time Frame: 6 months
Polymorphisms of vitamin D receptor gene: Cdx2, Fok1, Apa1, and Taq1
6 months
lipid profiles
Time Frame: 6 months
Serum concentrations of TG, TC, LDLC, and HDLC
6 months
25OHD
Time Frame: 6 months
Plasma 25-hydroxyvitamin D concentration
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2013

Primary Completion (Actual)

January 31, 2014

Study Completion (Actual)

October 31, 2016

Study Registration Dates

First Submitted

January 10, 2021

First Submitted That Met QC Criteria

January 12, 2021

First Posted (Actual)

January 13, 2021

Study Record Updates

Last Update Posted (Actual)

January 13, 2021

Last Update Submitted That Met QC Criteria

January 12, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • QLS2015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyslipidemias

Clinical Trials on No intervention.

3
Subscribe